Grants and Contributions:
Title:
Prototype development for vitreous floater detection, tracking and laser treatment
Agreement Number:
991645
Agreement Value:
$355,200.00
Agreement Date:
Jun 1, 2022 - Dec 31, 2023
Description:
The detection, tracking and treatment of vitreous floaters in human eye is currently not possible with conventional imaging and laser technology. The proposed project involves design and development of medical device prototype that is intended to be dedicated solely for the accurate detection and treatment of vitreous floaters.
Organization:
National Research Council Canada
Expected Results:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Location:
Edmonton, Alberta, CA T6J 2V2
Reference Number:
172-2022-2023-Q1-991645
Agreement Type:
Contribution
Report Type:
Grants and Contributions
Recipient Business Number:
776889289
Recipient Type:
For-profit organization
Additional Information:
This agreement has been amended 1 time(s). The total amended value is 100,000 dollars.
Amendment Date
Mar 9, 2023
Recipient's Legal Name:
PulseMedica Corp.
Federal Riding Name:
Edmonton Riverbend
Federal Riding Number:
48018
Program:
Industrial Research Assistance Program – Contributions to Firms
Program Purpose:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Coverage:
IRAP Contributions to Firms projects stimulate wealth creation for Canada through technological innovation.
NAICS Code:
334512
Amendments: